HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Min Wang Selected Research

Antisense RNA (Anti-Sense RNA)

1/2022OPA Interacting Protein 5 Antisense RNA 1 Expedites Cell Migration and Invasion Through FOXM1/ Wnt/β-Catenin Pathway in Pancreatic Cancer.
12/2021Inhibition of the long non-coding RNA UNC5B-AS1/miR-4455/RSPO4 axis reduces cervical cancer growth in vitro and in vivo.
1/2021Long non-coding RNA HAND2-AS1 inhibits gastric cancer progression by suppressing TCEAL7 expression via targeting miR-769-5p.
11/2020LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
3/2020Long non-coding RNA LOC285194 in cancer.
1/2020Long Non-Coding RNA HAND2-AS1 Inhibits Growth and Migration of Gastric Cancer Cells Through Regulating the miR-590-3p/KCNT2 Axis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Min Wang Research Topics

Disease

499Neoplasms (Cancer)
12/2022 - 01/2002
127Infections
12/2022 - 03/2002
123Inflammation (Inflammations)
11/2022 - 01/2005
84Breast Neoplasms (Breast Cancer)
10/2022 - 05/2003
67Neoplasm Metastasis (Metastasis)
01/2022 - 05/2003
55Carcinogenesis
01/2022 - 08/2003
51Leukemia
03/2022 - 02/2005
43Alzheimer Disease (Alzheimer's Disease)
06/2022 - 04/2008
36Hypoxia (Hypoxemia)
05/2022 - 12/2005
36Carcinoma (Carcinomatosis)
01/2022 - 11/2002
36Prostatic Neoplasms (Prostate Cancer)
10/2021 - 09/2002
35Fibrosis (Cirrhosis)
04/2022 - 08/2002
34Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2022 - 03/2005
34Lung Neoplasms (Lung Cancer)
06/2022 - 03/2003
33Hepatocellular Carcinoma (Hepatoma)
03/2022 - 10/2005
33Pancreatic Neoplasms (Pancreatic Cancer)
03/2022 - 10/2005
32Cognitive Dysfunction
10/2022 - 10/2012
32Hypertension (High Blood Pressure)
01/2022 - 03/2002
31Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 01/2002
31Pain (Aches)
01/2022 - 11/2005
30Body Weight (Weight, Body)
07/2022 - 10/2003
29Reperfusion Injury
01/2022 - 09/2006
26Stomach Neoplasms (Stomach Cancer)
07/2021 - 03/2006
25Stroke (Strokes)
05/2022 - 08/2004
24Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2008
24Insulin Resistance
07/2021 - 07/2004
24Ischemia
01/2020 - 03/2002
23Wounds and Injuries (Trauma)
04/2022 - 01/2002
22Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 02/2012
22Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 08/2003
21Hemorrhage
06/2022 - 07/2006
21Atherosclerosis
05/2022 - 03/2007
21Myocardial Infarction
01/2022 - 01/2005
21Parkinson Disease (Parkinson's Disease)
01/2022 - 04/2008
20Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 07/2003
19Colonic Neoplasms (Colon Cancer)
12/2022 - 03/2005
19Type 2 Diabetes Mellitus (MODY)
11/2022 - 07/2004
19COVID-19
10/2022 - 01/2020
19Adenocarcinoma
03/2022 - 06/2003
18Obesity
07/2022 - 05/2009
18Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2022 - 06/2005
18Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 08/2005
18Hyperglycemia
01/2022 - 09/2011
17Ischemic Stroke
09/2022 - 03/2010
17Periodontitis
02/2022 - 02/2010
16Glioma (Gliomas)
07/2022 - 10/2007
16Non-alcoholic Fatty Liver Disease
06/2022 - 05/2011
16Myocardial Ischemia (Ischemic Heart Diseases)
01/2022 - 09/2006
16Lymphatic Metastasis
01/2021 - 11/2002
16Allergic Rhinitis
01/2021 - 09/2003
15Infarction (Infarctions)
01/2022 - 01/2006
15Thrombosis (Thrombus)
12/2021 - 01/2012

Drug/Important Bio-Agent (IBA)

198Proteins (Proteins, Gene)FDA Link
12/2022 - 03/2002
81Biomarkers (Surrogate Marker)IBA
12/2022 - 08/2008
80CytokinesIBA
06/2022 - 10/2003
78Pharmaceutical PreparationsIBA
08/2022 - 06/2006
70Messenger RNA (mRNA)IBA
12/2022 - 03/2002
69MicroRNAs (MicroRNA)IBA
02/2022 - 01/2007
65Biological ProductsIBA
06/2022 - 11/2002
48Small Interfering RNA (siRNA)IBA
01/2022 - 08/2008
45Glucose (Dextrose)FDA LinkGeneric
07/2022 - 07/2006
44Peptides (Polypeptides)IBA
06/2022 - 01/2003
43EnzymesIBA
10/2022 - 08/2002
43AntibodiesIBA
10/2022 - 04/2004
42DNA (Deoxyribonucleic Acid)IBA
06/2022 - 02/2004
36Long Noncoding RNAIBA
01/2022 - 05/2016
31AntigensIBA
12/2022 - 03/2002
31Retinaldehyde (Retinal)IBA
07/2022 - 01/2004
30Therapeutic UsesIBA
09/2022 - 07/2005
29VaccinesIBA
07/2022 - 03/2002
29RNA (Ribonucleic Acid)IBA
03/2022 - 06/2002
26CollagenIBA
02/2022 - 02/2005
25LipidsIBA
07/2022 - 04/2010
25Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 03/2005
24Interleukin-6 (Interleukin 6)IBA
02/2022 - 04/2010
24AntioxidantsIBA
01/2022 - 01/2009
24AutoantibodiesIBA
01/2022 - 07/2002
23Monoclonal AntibodiesIBA
06/2022 - 07/2005
22Transcription Factors (Transcription Factor)IBA
01/2022 - 12/2005
22CateninsIBA
01/2022 - 09/2012
22CalciumIBA
01/2022 - 04/2011
21Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 06/2013
20Insulin (Novolin)FDA Link
07/2022 - 04/2006
20Chimeric Antigen ReceptorsIBA
03/2022 - 02/2016
20Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 08/2006
18Phosphotransferases (Kinase)IBA
11/2021 - 06/2006
18LigandsIBA
06/2021 - 11/2009
17CholesterolIBA
12/2022 - 10/2008
17Cadherins (E-Cadherin)IBA
10/2022 - 09/2008
16Indicators and Reagents (Reagents)IBA
01/2022 - 01/2006
16Matrix Metalloproteinases (MMPs)IBA
08/2021 - 01/2002
15Caspase 3 (Caspase-3)IBA
10/2022 - 11/2005
15C-Reactive ProteinIBA
10/2022 - 07/2004
15Doxorubicin (Adriamycin)FDA LinkGeneric
08/2022 - 01/2013

Therapy/Procedure

220Therapeutics
12/2022 - 08/2002
78Drug Therapy (Chemotherapy)
07/2022 - 12/2006
33Immunotherapy
07/2022 - 12/2005
25Radiotherapy
01/2022 - 02/2004
18Chinese Traditional Medicine (Traditional Chinese Medicine)
10/2021 - 04/2015
15Pancreaticoduodenectomy
03/2022 - 06/2013